维普中文期刊产品整合服务
21篇 您的检索式:作者名="Karsdal M A"
    题名 作者 年代 出处 被引量
1Should sub- chondral bone turnover be targeted when treating osteoarthritis? 显示文摘KARSDAL M A I EEM1NG D J DAM E B 2008Osteoarthritis Cartilage2008,16,6:1
2Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation显示文摘Karsdal M A Sumer E U Wulf H 2007Arthritis Rheum2007,56,5:1
3The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation显示文摘GARNERO P FERRERAS M KARSDAL M A 2003J Bone Miner Res2003,18,5:1
4Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis-the effect of sex,Kellgren-Lawrence(KL)score,Body Mass Index(BMI),oral salmon calcitonin(s CT)treatment and diurnal variation显示文摘Karsdal M A Byrjalsen I Bay-Jensen A C 2010BMC Musculoskeletal Disorders2010,11,:1
5Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation显示文摘Karsdal M A Byrjalsen I Leeming D J 2008BMC Musculoskelet Disord2008,18,9:1
6The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation 显示文摘Garnero P Ferreras M Karsdal M A 2003Journal of Bone and Mineral Research2003,18,5:1
7Should subchondral bone turnover be targeted when treating osteoarthritis? 显示文摘Karsdal M A Leeming D J Dam E B 2008Osteoarthritis Cartilage2008,16,6:1
8Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis显示文摘Karsdal M A Larsen L Engsig M T 2002J Biol Chem2002,277,44:1
9Biochemical Markers and the FDA Critical Path: How Biomarkers May Con- tribute to the Understanding of Pathophysiology and Provide U- nique and Necessary Tools for Drug Development 显示文摘Karsdal M A Henriksen K Leeming D J 2009Biomark- ers2009,14,3:1
10A- cidification of the osteoclastic resorption compartment pro- vides insight into the coupling of bone formation to bone re- sorption显示文摘KARSDAL M A HENRIKSEN K SORENSEN M G 2005Am J Pathol2005,166,2:1
11The type Ⅰ collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bonecollagendegradation显示文摘Garnero P Ferreras M Karsdal M A 2003J Bone Miner Res2003,18,5:1
12Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity显示文摘Karsdal M A Madsen S H Christiansen C 0,,03:1
13The type Ⅰ collagen fragments ICTP and CTx reveal distinct enzymatic pathways of bone collagen degradation显示文摘Garnero P Ferreras M Karsdal M A 2003J Bone Miner Res2003,18,5:1
14Should subchondral bone lurnover be targeted when treating osteoarthritis 显示文摘KARSDAL M A LEEMING D J DAM E B 2008Osteoarthritis and Cartilage2008,16,6:1
15Should subchondral bone turnover be targeted when treating osteoarthritis显示文摘Karsdal M A Leeming D J Dam E B 2008Osteoarth-ritis Cartilage2008,16,6:1
16The type I collagen fragments ICTP and CTX reveal dis- tinct enzymatic pathways of bone collagen degradation 显示文摘Garneto P Ferreras M Karsdal M A 2003J Bone MineRes2003,18,5:1
17The typeⅠcollagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation显示文摘Garnero P Ferreras M Karsdal M A 2003J Bone Mine Res2003,18,5:1
18The type Ⅰ collagen fragments ICTP and CTx reveal distinct enzymatic path-ways of bone collagen degradation显示文摘Garnero P Ferreras M Karsdal M A 2003J Bone Miner Res2003,18,5:1
19The type I collagen fragments ICTP and CTX re- veal distinct enzymatic pathways of bone collagen degradation显示文摘GARNER() P FERRERAS M KARSDAL M A 2003J Bone Miner Res2003,18,:1
20The type Ⅰ collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation显示文摘GARNERO P FERRERAS M KARSDAL M A 2003J Bone Mine Res2003,18,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费